Although this evidence suggests a pro-tumorigenic role of mitochondrial fusion, other studies should be carried out to determine if the pharmacological inhibition of OPA1 in PDAC cells curtails tumor growth by angiogenesis inhibition, as has already been reported in vivo models of melanoma and breast adenocarcinoma [79,84], or directly affects tumor cells. The gene discussed is OPA1; the disease is melanoma.